ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $860,394 | +18.8% | 65,479 | +13.9% | 0.00% | 0.0% |
| Q2 2023 | $724,046 | -43.8% | 57,464 | -41.8% | 0.00% | -50.0% |
| Q1 2023 | $1,288,909 | -19.0% | 98,767 | +9.5% | 0.00% | 0.0% |
| Q4 2022 | $1,590,669 | -99.9% | 90,174 | +8.2% | 0.00% | 0.0% |
| Q2 2022 | $1,235,502,000 | -54.5% | 83,311 | -30.9% | 0.00% | -50.0% |
| Q1 2022 | $2,714,133,000 | -4.3% | 120,521 | -21.6% | 0.00% | 0.0% |
| Q4 2021 | $2,835,544,000 | -19.6% | 153,688 | -41.7% | 0.00% | -20.0% |
| Q3 2021 | $3,526,110,000 | -7.2% | 263,733 | +28.5% | 0.01% | 0.0% |
| Q2 2021 | $3,799,252,000 | -56.3% | 205,254 | -64.6% | 0.01% | -61.5% |
| Q1 2021 | $8,694,075,000 | +169.7% | 579,026 | +159.4% | 0.01% | +116.7% |
| Q4 2020 | $3,223,788,000 | +879.1% | 223,254 | +451.9% | 0.01% | – |
| Q3 2020 | $329,255,000 | +74.1% | 40,449 | +44.8% | 0.00% | – |
| Q2 2020 | $189,093,000 | -75.2% | 27,931 | -74.2% | 0.00% | -100.0% |
| Q1 2020 | $763,263,000 | +21.3% | 108,418 | +69.1% | 0.00% | +100.0% |
| Q4 2019 | $629,181,000 | +78.6% | 64,104 | +99.8% | 0.00% | 0.0% |
| Q3 2019 | $352,348,000 | -2.2% | 32,090 | +3.6% | 0.00% | 0.0% |
| Q2 2019 | $360,100,000 | +2.8% | 30,963 | -15.6% | 0.00% | 0.0% |
| Q1 2019 | $350,147,000 | +1131.3% | 36,703 | +1144.2% | 0.00% | – |
| Q4 2018 | $28,438,000 | -89.1% | 2,950 | -83.9% | 0.00% | – |
| Q3 2018 | $260,462,000 | +2.0% | 18,278 | -14.1% | 0.00% | – |
| Q2 2018 | $255,468,000 | -90.6% | 21,289 | -90.3% | 0.00% | -100.0% |
| Q1 2018 | $2,713,888,000 | -30.4% | 219,748 | -18.1% | 0.01% | -16.7% |
| Q4 2017 | $3,901,684,000 | +53.0% | 268,157 | +49.3% | 0.01% | 0.0% |
| Q3 2017 | $2,550,200,000 | -1.7% | 179,667 | -11.3% | 0.01% | -25.0% |
| Q2 2017 | $2,593,643,000 | -23.7% | 202,588 | -24.0% | 0.01% | -11.1% |
| Q1 2017 | $3,401,382,000 | +455.7% | 266,568 | +355.6% | 0.01% | +200.0% |
| Q4 2016 | $612,136,000 | +125.7% | 58,506 | +184.1% | 0.00% | +200.0% |
| Q3 2016 | $271,236,000 | -77.6% | 20,595 | -78.4% | 0.00% | -80.0% |
| Q2 2016 | $1,211,580,000 | +569.9% | 95,400 | +596.8% | 0.01% | +400.0% |
| Q1 2016 | $180,871,000 | -71.2% | 13,692 | -66.4% | 0.00% | -50.0% |
| Q4 2015 | $627,104,000 | +8457.6% | 40,774 | +6799.2% | 0.00% | – |
| Q3 2015 | $7,328,000 | -97.4% | 591 | -97.1% | 0.00% | -100.0% |
| Q2 2015 | $281,439,000 | +356.7% | 20,573 | +299.2% | 0.00% | – |
| Q1 2015 | $61,630,000 | +38.7% | 5,153 | +48.1% | 0.00% | – |
| Q4 2014 | $44,427,000 | -22.2% | 3,479 | -18.3% | 0.00% | – |
| Q3 2014 | $57,129,000 | +463.2% | 4,257 | +573.6% | 0.00% | – |
| Q2 2014 | $10,144,000 | -93.9% | 632 | -94.2% | 0.00% | – |
| Q1 2014 | $166,583,000 | +310.0% | 10,945 | +316.5% | 0.00% | – |
| Q4 2013 | $40,629,000 | -100.0% | 2,628 | -100.0% | 0.00% | -100.0% |
| Q2 2013 | $687,330,000,000 | – | 7,000,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |